SAM
REGN icon

Shikiar Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Shikiar Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-550
Closed -$349K – 83
2025
Q1 		$349K Sell
550
-220
-29% -$151K 0.1% 63
2024
Q4 		$548K Sell
770
-17
-2% -$14.3K 0.15% 57
2024
Q3 		$827K Sell
787
-12
-2% -$13.4K 0.22% 52
2024
Q2 		$840K Sell
799
-50
-6% -$48.5K 0.22% 47
2024
Q1 		$817K Buy
849
+11
+1% +$10.5K 0.24% 46
2023
Q4 		$736K Sell
838
-1,070
-56% -$881K 0.23% 42
2023
Q3 		$1.57M Sell
1,908
-358
-16% -$281K 0.55% 36
2023
Q2 		$1.63M Sell
2,266
-57
-2% -$43.9K 0.52% 36
2023
Q1 		$1.91M Buy
+2,323
New +$1.75M 0.68% 32
2022
Q3 		$1.64M Sell
2,382
-584
-20% -$368K 0.66% 33
2022
Q2 		$1.75M Sell
2,966
-653
-18% -$424K 0.67% 32
2022
Q1 		$2.53M Buy
3,619
+35
+1% +$22.1K 0.72% 29
2021
Q4 		$2.26M Sell
3,584
-343
-9% -$211K 0.58% 36
2021
Q3 		$2.38M Buy
3,927
+1,917
+95% +$1.19M 0.67% 35
2021
Q2 		$1.12M Buy
2,010
+393
+24% +$199K 0.32% 54
2021
Q1 		$765K Sell
1,617
-3,644
-69% -$1.77M 0.26% 56
2020
Q4 		$2.54M Sell
5,261
-7,009
-57% -$3.78M 0.92% 30
2020
Q3 		$6.87M Buy
12,270
+3,295
+37% +$2M 2.64% 10
2020
Q2 		$5.6M Buy
+8,975
New +$5.09M 2.55% 11

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Shikiar Asset Management's REGN Position: Q2 2025 in Review

Shikiar Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 550 shares — an estimated $349K sold.

Shikiar Asset Management first reported a position in REGN in Q2 2020 and held it in 19 quarters. The position peaked at $6.87M in Q3 2020. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Shikiar Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Shikiar Asset Management sold 550 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $349K.
  • Shikiar Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and held it in 19 quarters.
  • Shikiar Asset Management's Regeneron Pharmaceuticals position peaked at $6.87M in Q3 2020.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Shikiar Asset Management's 13F filing for Q2 2025, filed 24 Jul 2025.